13F HOLDINGS REPORT
Ally Bridge Group (NY) LLC
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0000950123-25-005586
Total Value
$110.9M
Positions
28
Other Managers
1
Confidential Omitted
No
Holdings (28)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 281,139 | $12.4M | 11.18% |
| 2 | VERONA PHARMA PLC - ADR | 925050106 | 139,067 | $8.8M | 7.96% |
| 3 | SOLENO THERAPEUTICS INC | SLNO | 120,449 | $8.6M | 7.76% |
| 4 | AXSOME THERAPEUTICS INC | AXSM | 72,113 | $8.4M | 7.58% |
| 5 | TARSUS PHARMACEUTICALS INC | TARS | 127,932 | $6.6M | 5.92% |
| 6 | BLUEPRINT MEDICINES CORP | 09627Y109 | 74,192 | $6.6M | 5.92% |
| 7 | INSMED INC | INSM | 85,110 | $6.5M | 5.85% |
| 8 | AXSOME THERAPEUTICS INC | AXSM | 50,000 | $5.8M | 5.26% |
| 9 | TREVI THERAPEUTICS INC | TRVI | 686,219 | $4.3M | 3.89% |
| 10 | PRAXIS PRECISION MEDICINES I | PRAX | 95,582 | $3.6M | 3.26% |
| 11 | CENTESSA PHARMACEUTICALS-ADR | CNTA | 243,086 | $3.5M | 3.15% |
| 12 | ENLIVEN THERAPEUTICS INC | ELVN | 169,774 | $3.3M | 3.01% |
| 13 | MERUS NV | N5749R100 | 77,896 | $3.3M | 2.96% |
| 14 | GERON CORP | GERN | 2,056,637 | $3.3M | 2.95% |
| 15 | CG ONCOLOGY INC | CGON | 132,298 | $3.2M | 2.92% |
| 16 | ATYR PHARMA INC | ATYR | 777,020 | $2.3M | 2.12% |
| 17 | TECTONIC THERAPEUTIC INC | TECX | 132,222 | $2.3M | 2.11% |
| 18 | XENON PHARMACEUTICALS INC | XENE | 69,603 | $2.3M | 2.11% |
| 19 | MIND MEDICINE MINDMED INC | 60255C885 | 390,143 | $2.3M | 2.06% |
| 20 | EDGEWISE THERAPEUTICS INC | EWTX | 102,650 | $2.3M | 2.04% |
| 21 | EDGEWISE THERAPEUTICS INC | EWTX | 100,000 | $2.2M | 1.98% |
| 22 | JANUX THERAPEUTICS INC | JANX | 81,292 | $2.2M | 1.98% |
| 23 | DIANTHUS THERAPEUTICS INC | DNTH | 80,584 | $1.5M | 1.32% |
| 24 | WHITEHAWK THERAPEUTICS INC | WHWK | 817,939 | $1.5M | 1.31% |
| 25 | KORRO BIO INC | KRRO | 59,723 | $1.0M | 0.94% |
| 26 | PROMIS NEUROSCIENCES INC | PMN | 1,484,699 | $1.0M | 0.93% |
| 27 | TYRA BIOSCIENCES INC | TYRA | 107,244 | $997,369 | 0.90% |
| 28 | CONTEXT THERAPEUTICS INC | CNTX | 1,157,448 | $708,358 | 0.64% |